FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
HOUSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (āFibroBiologicsā), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the ...
1 day ago